Vivani MedicalVANI
Market Cap: $64.6M
About: Vivani Medical Inc is a preclinical-stage biopharmaceutical company. It develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division.
Employees: 37
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
8% more funds holding
Funds holding: 25 [Q1] → 27 (+2) [Q2]
0% more funds holding in top 10
Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
0.8% less ownership
Funds ownership: 11.16% [Q1] → 10.36% (-0.8%) [Q2]
32% less call options, than puts
Call options by funds: $97K | Put options by funds: $142K
37% less capital invested
Capital invested by funds: $11.4M [Q1] → $7.18M (-$4.17M) [Q2]
Research analyst outlook
We haven’t received any recent analyst ratings for VANI.
Financial journalist opinion
Based on 3 articles about VANI published over the past 30 days